Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06507943 · ClinicalTrials.gov registry record · NA
Community Health Equity Accelerator (CHEA) Pediatric Asthma Intervention
A NA study of Asthma in Children, sponsored by Yale University.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06507943: Active NA study of Asthma in Children, sponsored by Yale University.
NCT06507943 is a NA study of Asthma in Children that is active but no longer recruiting, run by Yale University. The registered enrollment target is 50 participants, below the 204-participant average among 44 other Asthma in Children trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06507943, a NA study of Asthma in Children, is active but no longer recruiting, sponsored by Yale University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot is to initiate an academic-community partnership and launch a multi-level intervention that includes an asthma exposure pathway (an online decision support and resource) and a health Promotora program that will provide culturally responsive asthma support alongside legal and medical services to improve access to asthma care and ultimately improve asthma-related outcomes in the New Haven region.
Primary Outcome
Percent of referred participants (from all referrals placed) to the newly-established asthma home visiting Promotora Program that resulted in a home visit (in-person or virtual)
Conditions Studied
Interventions
- BEHAVIORAL Promotora Home Visit
Study Locations (1)
Connecticut
- Yale - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-09-16 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What the registry record for NCT06507943 still lists
NCT06507943 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 204-participant average among 44 other Asthma in Children trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Asthma in Children appearing as the primary indexed condition, and to 1 intervention - of which Promotora Home Visit is the first listed.
NCT06507943 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06507943 about?
NCT06507943 is a clinical study titled "Community Health Equity Accelerator (CHEA) Pediatric Asthma Intervention". The purpose of this pilot is to initiate an academic-community partnership and launch a multi-level intervention that includes an asthma exposure pathway (an online decision support and resource) and a health Promotora program that will provide culturally responsive asthma support alongside legal an...
What is the current status of trial NCT06507943?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-09-16. Estimated completion is 2027-12-31.
What conditions does trial NCT06507943 study?
This clinical trial studies the following conditions: Asthma in Children.
What interventions are being tested in trial NCT06507943?
The interventions under investigation include: Promotora Home Visit (BEHAVIORAL).
Who is sponsoring clinical trial NCT06507943?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06507943 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma in Children
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06507943's enrollment target sits among peer trials
50 31st of 44 higher than 13 of 44 other Asthma in Children trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma in Children trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Action Towards Health Equity and Improved Air Quality in the Duwamish Valley: A Multilevel Asthma Intervention
RECRUITING · NA
-
SMART Implementation-Effectiveness Trial 1
RECRUITING · NA
-
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
RECRUITING · NA
-
A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)
RECRUITING · NA
-
Impact of Sleep Duration on Immune Balance in Urban Children With Asthma
RECRUITING · NA
-
Reducing Asthma Attacks in Disadvantaged School Children With Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI